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Available online 4 November 2014AbstractThe genomic sequence of Clostridium chauvoei, the etiological agent of blackleg, a severe disease of ruminants with high mortality specified
by a myonecrosis reveals a chromosome of 2.8 million base-pairs and a cryptic plasmid of 5.5 kilo base-pairs. The chromosome contains the
main pathways like glycolysis/gluconeogenesis, sugar metabolism, purine and pyrimidine metabolisms, but the notable absence of genes of the
citric acid cycle and deficient or partially deficient amino acid metabolism for Histidine, Tyrosine, Phenylalanine, and Tryptophan. These
essential amino acids might be acquired from host tissue damage caused by various toxins and by protein metabolism that includes 57 genes for
peptidases, and several ABC transporters for amino acids import.
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Clostridium chauvoei is a highly pathogenic, histotoxic,
anaerobic, endospore forming Gram-positive bacterium
causing blackleg, a severe disease of cattle, sheep and other
domestic animals. Blackleg is globally spread among rumi-
nants specified primarily as a myonecrosis with high mortality
causing significant losses in livestock production
[15,18,22,29]. C. chauvoei is one of the most pathogenic
Clostridium species. Although C. chauvoei is mainly consid-
ered to be specific to ruminants, rare fatal cases of fulminant
human gas gangrene and neutropenic enterocolitis caused by
C. chauvoei have been reported and it is assumed that preva-
lence of C. chauvoei causing disease in humans may be higher
than currently diagnosed [38,26]. Infection of ruminants by C.
chauvoei is caused by exposure of the animals to the pathogen
present in form of spores in the soil of “poisoned” pastures.
However, C. chauvoei has been detected in manure which also
represents a source of infection and can lead to contamination* Corresponding author. Tel.: þ41 31 631 2414; fax: þ41 31 631 2634.
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(http://creativecommons.org/licenses/by-nc-nd/3.0/).of pastures [2]. The infection by C. chauvoei leads to myo-
necrosis, oedemic lesions and fever, followed by lameness and
death [18,34]. Pathology of blackleg is mostly found in
muscular tissue of infected animals from where the pathogen
generally is isolated. Blackleg in cattle and sheep is controlled
worldwide by commercial vaccines that consist of whole,
inactivated bacteria and chemically toxoided culture super-
natants [35]. Furthermore, outer membrane proteins and
flagella have been proposed as immunogens against C. chau-
voei infections [5,6,24,25,31,32]. The molecular mechanisms
of pathogenicity of C. chauvoei in particular the spreading of
this pathogen from the digestive tract where it is taken up to
the muscle tissue where lesions are most abundant and where
the pathogen is found at high amounts assumingly due to
replication, is largely unknown.
Current knowledge reveals that toxins, DNAse, hyaluroni-
dase, neuraminidase and flagella seem to make a major
contribution to pathogenicity of C. chauvoei
[5,13,17,24,25,30,32,33,36]. Among the postulated toxins of
C. chauvoei, including an oxygen stable haemolysin, an oxy-
gen labile haemolysin and 27 kDa not further specified hae-
molytic protein. “Clostridium chauvoei toxin A” (CctA) anstitut Pasteur. This is an open access article under the CC BY-NC-ND license
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leucocidin superfamily of bacterial toxins has recently been
reported and was analysed in detail both genetically and bio-
chemically [13]. This leucocidin CctA represents the main
haemolytic and cytotoxic activity of C. chauvoei. Recombi-
nant polyhistidine tailed CctA produced in Escherichia coli
and purified after solubilisation in 6 M guanidine hydrochlo-
ride, by Ni2þ chelate affinity chromatography, is strongly
haemolytic [13] and does not lose haemolytic activity after
exposure to atmospheric oxygen [13]. Furthermore, guinea
pigs vaccinated with inactivated recombinant CctA were pro-
tected against challenge with virulent C. chauvoei, thus
showing its central role in virulence and its potential in im-
mune protection. Besides CctA, the genetic basis for the sia-
lidase NanA has been determined [36]. Besides these two
specific virulence genes and genes encoding flagellar antigens,
little is known on the genetics of C. chauvoei. Very recently,
we have determined the genome sequence of a virulent strain
of C. chauvoei (JF4335) isolated from a cattle that succumbed
of blackleg in 2004 [11]. This is currently the only compre-
hensive genomic dataset of C. chauvoei (GenBank/EMBL
accession number CBML0000000000.1). The current study
represents a comprehensive genomic analysis of C. chauvoei
aiming in enhancing knowledge about virulence and adapta-
tion of this clostridium to infect via ingestion and induce
myonecrosis in muscle tissue.
2. Results and discussionFig. 1. Agarose gel analysis of total genomic DNA extracted from C. chauvoei
JF4335 revealing the presence of a medium copy number plasmid marked by2.1. C. chauvoei general genome statistics overview and
comparative genomicsarrow.
Table 1
General genomic features predicted for C. chauvoei JF4335.
General feature Number or % of the genome
Genome
Number of ORFs 2630
Chromosome
Size (bp) 208250126
G þ C content 28.17
Number of ORFs 20628
CDS numbers 20567
Assigned function 10935
Ribosomal RNA operons 5e10
Transfer RNA 50
Bacteriophage or phage-like 2 1
Plasmid 1
Plasmid size (bp) 50566
Plasmid G þ C content 25.28The genome of C. chauvoei strain JF4335 is estimated to
consist of a single circular chromosome of 2.8 million base-
pairs (Mbp). The currently available draft genome sequence is
composed of 12 contigs covering a genome size of 208250126
base-pairs (bp) [11]. Moreover it contains a cryptic plasmid of
5.5 kilo base-pairs (kbp), which is present as medium copies
per chromosome equivalent as estimated from total genomic
DNA extraction (Fig. 1). The genome of the most frequently
encountered pathogenic and also commensal Clostridium
species, Clostridium perfringens, varies between 2.9 and
3.4 Mbp and contains various plasmids, that of Clostridium
botulinum between 3.2 and 4.2 MBp and that of the meta-
bolically diverse species Clostridium acetobutylicum is
4.1 Mbp. The relatively small genome of C. chauvoei as
compared to other Clostridium sp. reflects its restricted envi-
ronment, the bovine, caprine and ovine host, to which it is
adapted and where the bacterium is able to replicate. The draft
genome of C. chauvoei JF4335 contains 2630 predicted open
reading frames (ORFs) of which 1935 protein sequences could
be assigned and 632 ORFs represent hypothetical proteins that
could not be assigned (Table 1). Of the assigned proteins most
(259) are devoted to carbohydrate biosynthesis as revealed by
RAST analysis (http://rast.nmpdr.org/) [28], showing the
importance of carbohydrates for this pathogen both in the
capsulated vegetative form during infection and in thesporulated form during rest and persistence in the environment
(Fig. 2). Next frequent, 158 genes are involved in biosynthesis
of cofactors, vitamins and prosthetic groups, 138 represent cell
wall and capsule formation genes, 69 are directly involved in
dormancy and sporulation, 65 are devoted to motility and
chemotaxis, 60 represent stress protein genes, 44 are involved
in antibiotic and metal resistance and 13 encode confirmed or
Fig. 2. Representation assigned proteins of the genome sequence of C. chauvoei arranged by the various functional groups.
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(Table 2).
The putative origin of replication oriC consists of a DnaA
binding domain including the nona-nucleotide consensus
sequence TTATCCACA, followed by CDS comprising the
replication initiation protein DnaA, DNA polymerase III beta-
clamp DnaN, RecF GyrB and GyrA. The locus of the origin of
replication was further supported by GC skew analysis
calculated in 1000 bp windows across the genome. The scaf-
fold containing the DnaA gene (NZ_CBML010000008.1 GI:
546551543) displays a characteristic peak near the position of
this gene, adding more weight to the prediction (Fig. 3) (http://
gcat.davidson.edu/DGPB/gc_skew/gc_skew.html).
The genome of C. chauvoei JF4335 reveals six genes
encoding the RNA polymerase s70 factor, and each a gene for
alternative sigma factors s54, s24 and sH. Furthermore there is
a gene encoding an anti-sigma F factor and a gene for an anti-
sigma F factor antagonist, which both are supposedly involved
in the regulation of sporulation [10].
Analysis of the genome for the presence of prophages using
the PHAST server [39] lead to the discovery of an intact
prophage (26.2 kbp) similar to the C. perfringens bacterio-
phage fCP51 described recently [14] and having a similar
gene organisation as bacteriophage f3626 [40] showing in
particular genes for small and large subunit terminase, portal
protein, prohead protease, phage integrase, tail tape measure
protein and major tail protein (Fig. 4).The genome of C. chauvoei is very distant compared to
other known clostridia genomes even to its closest available
neighbour C. perfringens str.13. Comparing them using
MAUVE [8] we confirmed the very low conservation as only
few small co-linear blocks were identified (Fig. 5).2.2. Metabolic genesComparing metabolic pathway with RAST, we found that
the full presence of the main pathways like glycolysis/
gluconeogenesis (Fig. 6), sugar metabolism, purine and py-
rimidine metabolisms, as well as many amino acid metabo-
lisms. Here we report the notable absence of genes of the
citric acid cycle confirming similar discoveries in other
anaerobic Clostridium species [1]. However, bypass genes like
Si-citrate synthase or Re-citrate synthase [23] could not be
identified indicating that C. chauvoei must use another bypass
to the citric acid cycle.
Other pathways are deficient or partially deficient, mainly
in the amino acid metabolism like Histidine, Tyrosine,
Phenylalanine, and Tryptophan. These amino acids are
essential and therefore it explains why RAST analysis revealed
the presence of 136 functions involved in protein metabolism
whereof 57 genes, mostly encoding for peptidases, play a role
in protein degradation (Table 2). In addition several ABC
transporters responsible for amino acids import are also
identified. This reflects the protein rich environment, the
Table 2
Protein degradation genes.
ClpP ATP-dependent Clp protease proteolytic
subunit (EC 3.4.21.92)
ClpX ATP-dependent Clp protease ATP-binding subunit ClpX
ClpS ATP-dependent Clp protease adaptor protein ClpS
ClpA ATP-dependent Clp protease ATP-binding subunit ClpA
ClpC ATP-dependent Clp protease, ATP-binding subunit ClpC
ClpY ATP-dependent hsl protease ATP-binding subunit HslU
ClpQ ATP-dependent protease HslV (EC 3.4.25.-)
ClpB ClpB protein
NERP Nucleotide excision repair protein, with UvrB/UvrC motif
Lon ATP-dependent protease La (EC 3.4.21.53)
LonI ATP-dependent protease La (EC 3.4.21.53) Type I
LonII ATP-dependent protease La (EC 3.4.21.53) Type II
DP ATP-dependent protease domain protein (EC 3.4.21.-)
ClpXP ClpXP protease specificity-enhancing factor
DegS Outer membrane stress sensor protease DegS
DegQ Outer membrane stress sensor
protease DegQ, serine protease
AFG ATPase, AFG1 family
CtsR Transcriptional regulator CtsR
YacI Putative ATP:guanido phosphotransferase YacI (EC 2.7.3.-)
PilT Membrane-associated protein containing
RNA-binding TRAM domain and ribonuclease PIN-domain
Col Microbial collagenase (EC 3.4.24.3)
Col-Sec Microbial collagenase, secreted (EC 3.4.24.3)
VibLysin Vibriolysin, extracellular zinc protease (EC 3.4.24.25)
PseLysin Pseudolysin, extracellular zinc protease (EC 3.4.24.26)
BacLys Bacillolysin, extracellular neutral
metalloprotease (EC 3.4.24.28)
LytM Glycyl-glycine endopeptidase LytM precursor (EC
AcX Acylamino-acid-releasing enzyme (EC 3.4.19.1)
PyroGlu Pyrrolidone-carboxylate peptidase (EC 3.4.19.3)
IsoAsp- Isoaspartyl aminopeptidase (EC 3.4.19.5)
gamma-Glu Gamma-D-glutamyl-meso-diaminopimelate
peptidase (EC 3.4.19.11)
PepD Aminoacyl-histidine dipeptidase
(Peptidase D) (EC 3.4.13.3)
PepQ Xaa-Pro dipeptidase PepQ (EC 3.4.13.9)
PepE Alpha-aspartyl dipeptidase Peptidase E (EC 3.4.13.21)
DacA D-alanyl-D-alanine carboxypeptidase (EC 3.4.16.4)
GluCP Glutamate carboxypeptidase (EC 3.4.17.11)
Mur4pep Muramoyltetrapeptide carboxypeptidase (EC 3.4.17.13)
Zn-Dac Zinc D-Ala-D-Ala carboxypeptidase (EC 3.4.17.14)
CarbP-T Carboxypeptidase T (EC 3.4.17.18)
TaqCP Thermostable carboxypeptidase 1 (EC 3.4.17.19)
PepC Aminopeptidase C (EC 3.4.22.40)
YpdF Aminopeptidase YpdF (MP-, MA-, MS-, AP-, NP- specific)
YpdE Nondeblocking aminopeptidase YpdE (X-X-[^PR]- specific)
DbAMP Deblocking aminopeptidase (EC 3.4.11.-)
IadA Isoaspartyl dipeptidase (EC 3.4.19.5)
Asp-X Asp-X dipeptidase
Aat Leucyl/phenylalanyl-tRNA-protein transferase (EC 2.3.2.6)
Ate Arginine-tRNA-protein transferase (EC 2.3.2.8)
Dcp Dipeptidyl carboxypeptidase Dcp (EC 3.4.15.5)
PrlC Oligopeptidase A (EC 3.4.24.70)
Thimet Thimet oligopeptidase (EC 3.4.24.15)
MIPEP Mitochondrial intermediate peptidase,
mitochondrial precursor (EC 3.4.24.59)
PepA Cytosol aminopeptidase PepA (EC 3.4.11.1)
PepN Membrane alanine aminopeptidase N (EC 3.4.11.2)
PepP Xaa-Pro aminopeptidase (EC 3.4.11.9)
PepB Peptidase B (EC 3.4.11.23)
AmpY Aminopeptidase Y (Arg, Lys, Leu preference) (EC 3.4.11.15)
AmpS Aminopeptidase S (Leu, Val, Phe,
Tyr preference) (EC 3.4.11.24)
Fig. 3. Graphic representation of the GC skew of the C. chauvoei genome
close in the origin of replication.
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replication and growth activities under natural conditions.2.3. HaemolysinsC. chauvoei is a primary pathogen causing blackleg in ru-
minants. The complex pathogenicity of C. chauvoei is ex-
pected to require various virulence factors including potent
toxins but also enzymes and organelles enabling the bacterium
to reach its destination, the muscular tissue. It's very strong
haemolytic appearance in cultures on blood agar plates sup-
poses that one or several haemolysins of C. chauvoei represent
the main toxins and virulence factors. The potential direct
virulence genes found on the annotated genome of C. chauvoei
JF4335 as listed in Table 3 include 4 haemolysins, a haemo-
lysin belonging to the haemolysin III-superfamily, a haemo-
lysin A, a haemolysin of the XhlA type and the haemolytic
leucocidin CctA. The latter has been shown to represent the
major haemolytic and cytotoxic activity secreted by C. chau-
voei. This haemolytic activity is oxygen stable. Recombinant
inactivated CctA used as antigen for vaccination showed
nearly full protection in guinea pigs against challenge with
virulent C. chauvoei, hence indicating that this toxin represent
the main virulence factor of this pathogen [13]. The gene
encoding cctA showed remarkable genetic stability. The cctA
gene was found to be fully conserved within 7 C. chauvoei
strains isolated over a period of 54 years from blackleg in 6
countries of 4 continents with a single strain showing 3 single
nucleotide polymorphisms (SNP) all affecting the third
nucleotide of the codon and not affecting the encoded amino
acid [13].
The putative haemolysin III represents a protein of 220
amino acids (aa) with a molecular mass of 25 kDa and a
calculated pI of 9.1 and characteristic domains of the hae-
molysin III-superfamily. This haemolysin could represent the
27 kDa haemolysin that was identified in C. chauvoei strain
C6H by Hang'ombe and collaborators [16]. A gene encoding a
highly similar Haemolysin III with 58% identical and 75%
Fig. 4. Genetic structure of the prophage fJF4335 found integrated in the chromosome of C. chauvoei.
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perfringens strains that were analysed genetically in detail.
Haemolysin III is referred as haemolysin D in C. perfringens.
Putative haemolysins of the haemolysin III-superfamily are
very widely spread in Gram-positive bacteria and are found in
pathogenic as well as in commensal and environmental species
such as Flavibacterium sp., Bacillus sp., Stenotrophomonas
sp., Paenibacillus sp., Photobacterium sp., Desulfitibacter sp.,
Desulfobacterium sp. where it is named haemolysin III or
alternatively haemolysin D. It has been described as one of the
haemolysin-toxins of Bacillus cereus [3,4]. The role of hae-
molysin III in pathogenicity of C. chauvoei is still unclear.
However in comparison with other bacterial species it seems
to play a minor role in virulence.
The putative haemolysin A found in the annotated genome
of C. chauvoei belongs to the FtsJ superfamily of RNA
methyltransferases. Its putative haemolytic function could not
be verified and it function in pathogenicity is questionable.
The FtsJ protein is a well conserved heat shock protein that is
found in all prokaryotes but also archaea and eukaryotes whereFig. 5. Graphic representation of the similarity between the chromosomes of C. cha
by MAUVE analysis.it is responsible for methylation of the 23S rRNA supposedly
in the late maturation phase of the ribosome. Hence ftsJ rep-
resents a house keeping gene and the designation ftsJ should
be used in the future for all organisms.
A further haemolysin found on the annotated genome of C.
chauvoei is a small 77 aa protein of 8.8 kDa belonging to the
haemolysin XhlA superfamily. Genes encoding homologues to
XhlA are found in many Gram-positive bacteria, in particular
in insect pathogen species of Paenibacillus, Bacillus, Clos-
tridium, but also in some C. botulinum and in Clostridium
glycolyticum. This latter is a spore forming environmental
bacterium also present in the natural gut microbiome of ani-
mals and humans. C. glycolyticum is sometimes found in
wounds abscesses of animals and humans but its role in
pathogenesis in not confirmed. Haemolysin XhlA was pri-
marily shown as a major virulence factor of Xenorhabdus
nematophila which is a pathogen for a variety of insects [7]. It
is therefore questionable if XhlA plays a role in pathogenicity
of blackleg by C. chauvoei, or if the gene is a requisite of
evolution of Clostridium species.uvoei JF4335 and C. perfringens strain 13, the closest related animal pathogen,
Fig. 6. Glycolysis/glycogenesis pathway. The blue boxed functions are annotated in the genome of C. perfringens. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
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Table 3
Primary virulence genes of Clostridium chauvoei JF4335.
Virulence factor Gene
designation
Protein nr Comment
Panton Valentine
leucocidin CctA
cctA 1863 Activity confirmed
Haemolysin III 276 Also named
haemolysin D
Haemolysin XhlA 799
(Haemolysin A)a ftsJ 1036 RNA
methyltransferase
Sialidase nanA 1464 Activity confirmed
Hyaluronidase H nagH 2049 Activity confirmed
Hyaluronidase J nagJ 1919
Patatine phospholipase 181
Patatine phospholipase 1777
Collagen binding protein 1915
Collagen binding protein 1916
Internalin A inlA1 2016
Internalin A inlA2 2017
a Correct annotation is FtsJ RNA methyltransferase.
390 J. Frey, L. Falquet / Research in Microbiology 166 (2015) 384e3922.4. Non-haemolysin virulence factorsBesides haemolysin- and putative haemolysin genes, C.
chauvoei contains a gene, nanA, encoding a sialidase whose
activity has been confirmed previously by expressing it in E.
coli. Sialidase activity could be obtained from a recombinant
protein expressed from a cloning vector containing the C.
chauvoei nanA gene [36]. Sialidases or neuraminidases
hydrolyse the a 2e3, a 2e6, a 2e8 glycosilic linkages of
terminal sialic residues in oligosaccharides, glycosaccarides,
glycoproteins and glycolipids and are known as virulence
factor by affecting the intracellular matrix and by undercutting
pathways in the host's immune regulation. Sialidase is sup-
posed to underpin the rapid spread of C. chauvoei in the tissue
of the infected host and has previously been suggested to play
an important role in blackleg [33]. The nanA gene and
secreted sialidase activity was found in all 7 C. chauvoei
strains mentioned above. However genetic differences of the
nanA gene was found among the various C. chauvoei strains,
in contrast to the leucocidin gene cctA [36].
Hyaluronidase is further enzyme affecting the intracellular
matrix of the host. The genome of C. chauvoei reveals two
different hyaluronidase genes, nagH and nagJ (Table 3) of
which the activity of nagH has been confirmed in our labo-
ratory (Frey and Wu¨thrich unpublished). Hyaluronidase,
similar to sialidase is thought to be involved in loosening the
intracellular matrix and tissue connections, thus favouring the
spread of C. chauvoei in the infected host.
The C. chauvoei genome furthermore reveals two genes
encoding for potential patatine phospholipases (PPARs).
PPARs belong to the ligand inducible nuclear receptors and
transcription factors in the steroid superfamily [20]. PPARg is
suggested to be beneficial in hyper-inflammatory diseases,
such as sepsis, by repressing expression of inflammatory genes
(inducible nitric oxide synthase, TNFa, or IL-1b) [37].
However, it can also provoke apoptosis which in the hyper-inflammatory phase of sepsis might be helpful by reducing
the number of immune cells that are involved in secreting high
amounts of pro-inflammatory mediators [37]. PPARs are
activated by ligands such as fatty acids, eicosanoids and oxi-
dised fatty acids [9,12,21,27].
Furthermore, two genes encoding potential collagen bind-
ing proteins as well as two genes encoding homologues to
internalin A, which are supposed to be involved in virulence
were found on the chromosome of C. chauvoei.
Although flagella are often not directly involved in viru-
lence, they might contribute to the infectious process by their
potential to provide the bacterium mobility and hence to reach
the target tissue where the bacterium causes tissue damage and
disease. Furthermore flagellar antigens have been studied in
detail in the view of their potential as valuable candidate an-
tigens for vaccines [24,25,30e32]. Twenty flagellar biosyn-
thesis genes were found on the coromosome of C. chauvoei in
four clusters, probably arranged in operons: fli
DMNFGIJLPSQ, flg KBCDG, flb D, the gene encoding the
flagellar protein 3 and the genes for flagellar hook biosynthesis
and hook length control proteins.2.5. Antibiotic resistanceAll above named strains of Clostridium chauvoei are sen-
sitive to all antibiotics tested that are currently used against
clostridial infections (Frey unpublished results). The minimal
inhibitory concentrations for strain JF4335 as determined in
Mueller Hinton II Broth using custom Sensititre™ suscepti-
bility plates (Trek Diagnostics Systems, East-Grinstead, En-
gland, and MCS Diagnostics BV, JL Swalmen, The
Netherlands) according to the CLSI guidelines [19] for C.
chauvoei strain were: Cephalotin 2 mg/ml, Clindamycin
0.5 mg/ml, Enrofloxacin 0.25 mg/ml, Erythromycin 0.25 mg/ml,
Penicillin <0.012 mg/ml, Vancomycin 1 mg/ml, Tetracyclin
1 mg/ml and Chloramphenicol <4 mg/ml. This reflects the fact
that blackleg is not treated with antibiotics due to its virulent
appearance leading to rapid death of the animal. It is therefore
surprising that C. chauvoei strain JF4335 harbours each a gene
potential for penicillin resistance, a b-lactamase (EC 3.5.2.6),
as well as an elongator Factor EF G type tetracycline resis-
tance gene potentially involved in protection of ribosomes
from tetracycline and catalysis and release of tetracycline
(tetM, tetO analogue) and a vancomycin B-type resistance
protein gene vanW, but no further genes potentially involved in
vancomycin resistance. Furthermore there are 9 genes
encoding potential Multi antimicrobial extrusion proteins
(Naþ/drug antiporters). However, these genes seem either not
to be expressed in C. chauvoei JF4335, or are expressed as
non-functional proteins or most probably have functions other
than export of antibiotics.
In conclusion, the genomic sequence of a virulent strain of
C. chauvoei gives insight in its particular lifestyle which im-
plies the replication in damaged host tissue during infection
and the various virulence genes that allow the pathogen to
reach the host tissue and prepare it for its replication. Potential
antibiotic resistance genes are present on the chromosome of
391J. Frey, L. Falquet / Research in Microbiology 166 (2015) 384e392C. chauvoei, although this pathogen is sensitive to the corre-
sponding antibiotics reflecting the fact that infected animals
are not treated with antibiotics.
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